You have 9 free searches left this month | for more free features.

Ethyl-EPA

Showing 1 - 25 of 432

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)

Withdrawn
  • Bipolar Disorder
  • Ethyl Eicosapentaenoic Acid
  • New York, New York
    New York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022

Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertriglyceridemia
  • Metformin Eicosapentaenoate
  • Metformin HCl and Vascepa
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Apr 25, 2022

Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)

Recruiting
  • Liver Metastasis
  • Colon Cancer
  • Icosapent Ethyl
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +12 more
Nov 7, 2022

COVID19 Trial in Rosario (Icosapent ethyl (IPE), Placebo)

Completed
  • COVID19
  • Icosapent ethyl (IPE)
  • Placebo
  • Rosario, Santa Fe, Argentina
    Instituto de Investigaciones Clínicas - Rosario
Sep 10, 2021

Type 2 Diabetes, Coronary Artery Disease Trial in Boston (Icosapent ethyl)

Terminated
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Icosapent ethyl
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 22, 2022

Healthy Adults Trial in Rimouski (MAG-EPA/MAG-DHA, TG-EPA/TG-DHA, EE-EPA/EE-DHA)

Completed
  • Healthy Adults
  • MAG-EPA/MAG-DHA
  • +2 more
  • Rimouski, Quebec, Canada
    SCF pharma
Apr 28, 2021

Healthy Trial in Sherbrooke (omega-3 fatty acid supplementation, corn/soybean oil )

Completed
  • Healthy
  • omega-3 fatty acid supplementation
  • corn/soybean oil placebo
  • Sherbrooke, Quebec, Canada
    PL Léveillé
May 6, 2020

Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver

Recruiting
  • Colon Cancer Liver Metastasis
  • Icosapent Ethyl Oral Capsule
  • Placebo
  • Leeds, United Kingdom
  • +1 more
Sep 27, 2021

Diabetes Type 2, Hypertriglyceridemia, Diabetes Trial in Ioannina (EPAVasc, Corn Oil)

Not yet recruiting
  • Diabetes Type 2
  • +2 more
  • EPAVasc
  • Corn Oil
  • Ioannina, Epirus, Greece
    Atherothrombosis Research Centre / Laboratory of Biochemistry, U
Nov 13, 2023

Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility, Low-density Lipoprotein Lipid Composition Trial in

Unknown status
  • Atherosclerosis
  • +3 more
  • Ethyl-Eicosapentaenoic Acid (E-EPA)
  • Helsinki, Finland
    Wihuri Research Institute
Nov 15, 2019

Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

Completed
  • Lipid Disorder
  • +2 more
  • Icosapent Ethyl 1000 MG [Vascepa]
  • Philadelphia, Pennsylvania
    Perelman School of Medicine at the University of Pennsylvania
Oct 15, 2021

Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)

Completed
  • Cardiovascular Diseases
  • Birmingham, Alabama
  • +409 more
Mar 21, 2022

Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule

Recruiting
  • Cardiovascular Diseases
  • +3 more
  • Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
  • North York, Ontario, Canada
  • +3 more
Nov 7, 2022

Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)

Completed
  • Colorectal Adenoma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Breast Cancer Trial in Kansas City (Omega-3 Fatty Acids, Placebo Capsule, Diet and Exercise)

Completed
  • Breast Cancer
  • Omega-3 Fatty Acids
  • +2 more
  • Kansas City, Kansas
    University of Kansas Medical Center, Breast Cancer Prevention Ce
Jan 6, 2022

Optimal Gastrointestinal Absorption of Omega-3 Trial in Brisbane (Product 1 - AquaCelle Fish Oil Triglyceride, Product 2 -

Not yet recruiting
  • Optimal Gastrointestinal Absorption of Omega-3
  • Product 1 - AquaCelle Fish Oil Triglyceride
  • +2 more
  • Brisbane, Queensland, Australia
    RDC Global Pty Ltd
Aug 8, 2022

Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )

Active, not recruiting
  • Alzheimer's Disease
  • icosapent ethyl (IPE)
  • gel cap placebo
  • Madison, Wisconsin
    William S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021

Absorption, Pharmacokinetics Trial in Esslingen (PL+ omega 3 fatty acids, FO EE fatty acids)

Active, not recruiting
  • Absorption
  • Pharmacokinetics
  • PL+ omega 3 fatty acids
  • FO EE fatty acids
  • Esslingen, Germany
    BioTeSys GmbH
Jan 31, 2023

Dyslipidemias, Atherosclerosis, Diabetes, Type 2 Trial (Omega 3-Atorvastatin, Atorvastatin-Ezetimibe)

Recruiting
  • Dyslipidemias
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    SNUBH
Oct 1, 2022

Breast Cancer, Ovarian Tumor, Pain Trial in Albuquerque (Omega-3 fatty acid, Placebo, Paclitaxel)

Completed
  • Breast Cancer
  • +2 more
  • Omega-3 fatty acid
  • +2 more
  • Albuquerque, New Mexico
  • +1 more
Oct 4, 2022

Healthy Trial in Sherbrooke (Omega-3 + vitamin K2 (monoacylglycerol form), Omega-3 + vitamin K2 (ethyl ester))

Completed
  • Healthy
  • Omega-3 + vitamin K2 (monoacylglycerol form)
  • Omega-3 + vitamin K2 (ethyl ester)
  • Sherbrooke, Quebec, Canada
    Centre de Recherche sur le Vieillissement
May 8, 2020

Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)

Recruiting
  • Healthy
  • Rodatristat Ethyl
  • +3 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 5, 2023

Physical Activity Trial (Enhance Physical Activity (EPA))

Not yet recruiting
  • Physical Activity
  • Enhance Physical Activity (EPA)
  • (no location specified)
Jan 18, 2023

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Inflammation; Skin, Resolution, Blister Trial in Boston (Lovaza, Cantharone, Phlebotomy)

Completed
  • Inflammation; Skin
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 25, 2022